Interactions of fungi with phagocytes

Current Opinion in Microbiology

Volumn 5, Issue 4, 2002, Pages 359-365

  Mansour, Michael K ^a   Levitz, Stuart M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL INTERACTION; CELL PROTECTION; DENDRITIC CELL; FUNGUS; HUMAN; MACROPHAGE; MYCOSIS; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; REVIEW;

FUNGI;

EID: 0036342776     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(02)00342-9     Document Type: Review

References (58)

1. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis
2. Dendritic cells and transmission of HIV-1
3. Dendritic cells pulsed with intact Streptococcus pneumoniae elicit both protein- and polysaccharide-specific immunoglobulin isotype responses in vivo through distinct mechanisms
4. Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity
5. Origin and differentiation of dendritic cells
6. Mouse and human dendritic cell subtypes
7. The plasticity of dendritic cell responses to pathogens and their components
8. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells
9. Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse Th cell-polarizing signals
10. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo
11. Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation
12. Candida albicans is phagocytosed, killed, and processed for antigen presentation by human dendritic cells
13. Histoplasma capsulatum yeasts are phagocytosed via very late antigen-5, killed, and processed for antigen presentation by human dendritic cells
14. Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus
15. Dendritic cell-mediated stimulation of the in vitro lymphocyte response to Aspergillus
16. Dendritic cells pulsed with Coccidioides immitis lysate induce antigen-specific naive T cell activation
17. The allergenic yeast Malassezia furfur induces maturation of human dendritic cells
18. IL-4 pretreatment selectively enhances cytokine and chemokine production in lipopolysaccharide-stimulated mouse peritoneal macrophages
19. Protection of bronchoalveolar macrophages by granulocyte-macrophage colony-stimulating factor against dexamethasone suppression of fungicidal activity for Aspergillus fumigatus conidia
20. In vivo GM-CSF prevents dexamethasone suppression of killing of Aspergillus fumigatus conidia by bronchoalveolar macrophages
21. Recombinant human macrophage colony-stimulating factor augments pulmonary host defences against Aspergillus fumigatus
22. Effects of macrophage colony-stimulating factor on antifungal activity of neonatal monocytes against Candida albicans
23. Effects of interleukin-13 on antifungal activity of human monocytes against Candida albicans
24. N K cells eliminate Cryptococcus neoformans by potentiating the fungicidal activity of macrophages rather than by directly killing them upon stimulation with IL-12 and IL-18
25. T cells augment monocyte and neutrophil function in host resistance against oropharyngeal candidiasis
26. Mechanism of action of antibody to capsular polysaccharide in Cryptococcus neoformans infection
27. Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans
28. Antibody efficacy in murine pulmonary Cryptococcus neoformans infection: A role for nitric oxide
29. Cryptococcus neoformans induces macrophage inflammatory protein 1 α (MIP-1α) and MIP-1β in human microglia: Role of specific antibody and soluble capsular polysaccharide
30. Cryptococcal polysaccharides bind to CD18 on human neutrophils
31. Toll-like receptor 4 mediates intracellular signaling without TNF-α release in response to Cryptococcus neoformans polysaccharide capsule
32. Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis
33. In vivo clearance of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans: A critical role for tissue macrophages
34. The WI-1 antigen of Blastomyces dermatitidis yeasts mediates binding to human macrophage CD11b/CD18 (CR3) and CD14
35. The WI-1 adhesin blocks phagocyte TNF-α production, imparting pathogenicity on Blastomyces dermatitidis
36. Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans
37. Role of intercellular adhesion molecule 1 in acute lung injury induced by candidemia
38. Role of alveolar macrophages in Candida-induced acute lung injury
39. Role of extracellular signal-regulated protein kinase cascade in macrophage killing of Candida albicans
40. Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm
41. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages
42. Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection
43. Nramp1 gene affects selective early steps in macrophage-mediated anti-cryptococcal defense
44. Urokinase-type plasminogen activator is required for the generation of a type 1 immune response to pulmonary Cryptococcus neoformans infection
45. Neutrophil granulocyte-committed cells can be driven to acquire dendritic cell characteristics
46. Neutrophil FcγRI as target for immunotherapy of invasive candidiasis
47. Deletion of the two-component histidine kinase gene (CHK1) of Candida albicans contributes to enhanced growth inhibition and killing by human neutrophils in vitro
48. Human neutrophil-mediated nonoxidative antifungal activity against Cryptococcus neoformans
49. Homodimeric theta-defensins from rhesus macaque leukocytes: Isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides
50. Lactoferrin peptide increases the survival of Candida albicans-inoculated mice by upregulating neutrophil and macrophage functions, especially in combination with amphotericin B and granulocyte-macrophage colony-stimulating factor
51. Variable correction of host defense following gene transfer and bone marrow transplantation in murine X-linked chronic granulomatous disease
52. Cryptococcal glucuronoxylomannan induces interleukin (IL)-8 production by human microglia but inhibits neutrophil migration toward IL-8
53. Cryptococcal glucuronoxylomannan delays translocation of leukocytes across the blood-brain barrier in an animal model of acute bacterial meningitis
54. Potent inhibition of neutrophil migration by cryptococcal mannoprotein-4-induced desensitization
55. Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors
56. The role of Toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis
57. Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection
58. Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity